| Date: 2020/08/20 | File Size: 289.87 MB |
| Duration: 00:00:10 | Frame Size: 1920 x 1080 |
The building housing BioMed Lublin is seen in Lublin, Poland on August 18, 2020. BioMed Lublin together with the Lublin Medical University announced a trial-ready version of their drug for the treatment of COVID-19 patients on August 18, 2020. The drug has been developed with plasma donated from blood taken from infected miners from the Silesia region of Poland.